vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and NOODLES & Co (NDLS). Click either name above to swap in a different company.
NOODLES & Co is the larger business by last-quarter revenue ($122.1M vs $62.1M, roughly 2.0× Cytek Biosciences, Inc.). NOODLES & Co runs the higher net margin — -7.5% vs -70.9%, a 63.4% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -4.1%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-2.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -1.2%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Noodles & Company is an American fast-casual restaurant that offers international and American noodle dishes in addition to soups and salads. Noodles & Company was founded in 1995 by Aaron Kennedy and is headquartered in Broomfield, Colorado. The company went public in 2013 and recorded a $457 million revenue in 2017. In mid-2022, there were 458 Noodles & Company locations across 31 states.
CTKB vs NDLS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $122.1M |
| Net Profit | $-44.1M | $-9.2M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | -5.2% |
| Net Margin | -70.9% | -7.5% |
| Revenue YoY | 8.1% | -4.1% |
| Net Profit YoY | -557.1% | 32.8% |
| EPS (diluted) | — | $-0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | — | ||
| Q3 25 | $52.3M | $122.1M | ||
| Q2 25 | $45.6M | $123.8M | ||
| Q1 25 | $41.5M | — | ||
| Q4 24 | $57.5M | $122.8M | ||
| Q3 24 | $51.5M | $127.4M | ||
| Q2 24 | $46.6M | $121.4M | ||
| Q1 24 | $44.9M | $124.3M |
| Q4 25 | $-44.1M | — | ||
| Q3 25 | $-5.5M | $-9.2M | ||
| Q2 25 | $-5.6M | $-9.1M | ||
| Q1 25 | $-11.4M | — | ||
| Q4 24 | $9.6M | $-6.8M | ||
| Q3 24 | $941.0K | $-13.6M | ||
| Q2 24 | $-10.4M | $-6.1M | ||
| Q1 24 | $-6.2M | $-6.1M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | — | ||
| Q3 25 | -17.6% | -5.2% | ||
| Q2 25 | -23.3% | -5.2% | ||
| Q1 25 | -36.1% | — | ||
| Q4 24 | 5.2% | -3.9% | ||
| Q3 24 | -8.2% | -9.0% | ||
| Q2 24 | -18.3% | -3.4% | ||
| Q1 24 | -23.9% | -3.7% |
| Q4 25 | -70.9% | — | ||
| Q3 25 | -10.5% | -7.5% | ||
| Q2 25 | -12.2% | -7.3% | ||
| Q1 25 | -27.5% | — | ||
| Q4 24 | 16.8% | -5.5% | ||
| Q3 24 | 1.8% | -10.7% | ||
| Q2 24 | -22.4% | -5.1% | ||
| Q1 24 | -13.8% | -4.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.20 | ||
| Q2 25 | — | $-0.20 | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-0.15 | ||
| Q3 24 | — | $-0.30 | ||
| Q2 24 | — | $-0.14 | ||
| Q1 24 | — | $-1.64 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $4.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $-38.9M |
| Total Assets | $461.5M | $280.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | $4.7M | ||
| Q2 25 | $75.5M | $1.4M | ||
| Q1 25 | $95.3M | — | ||
| Q4 24 | $98.7M | $3.3M | ||
| Q3 24 | $162.3M | $1.8M | ||
| Q2 24 | $177.9M | $1.3M | ||
| Q1 24 | $168.8M | $3.0M |
| Q4 25 | $341.7M | — | ||
| Q3 25 | $378.6M | $-38.9M | ||
| Q2 25 | $377.6M | $-13.9M | ||
| Q1 25 | $379.6M | — | ||
| Q4 24 | $395.7M | $3.7M | ||
| Q3 24 | $385.5M | $9.6M | ||
| Q2 24 | $389.1M | $21.9M | ||
| Q1 24 | $392.6M | $27.2M |
| Q4 25 | $461.5M | — | ||
| Q3 25 | $494.9M | $280.6M | ||
| Q2 25 | $493.3M | $319.4M | ||
| Q1 25 | $482.6M | — | ||
| Q4 24 | $499.5M | $340.5M | ||
| Q3 24 | $491.2M | $346.3M | ||
| Q2 24 | $483.7M | $360.4M | ||
| Q1 24 | $492.1M | $368.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $4.3M |
| Free Cash FlowOCF − Capex | $-1.8M | $-2.8M |
| FCF MarginFCF / Revenue | -2.9% | -2.3% |
| Capex IntensityCapex / Revenue | 1.6% | 5.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $-7.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | — | ||
| Q3 25 | $-3.9M | $4.3M | ||
| Q2 25 | $108.0K | $4.0M | ||
| Q1 25 | $-125.0K | — | ||
| Q4 24 | $2.0M | $5.8M | ||
| Q3 24 | $13.2M | $4.7M | ||
| Q2 24 | $6.2M | $7.0M | ||
| Q1 24 | $4.0M | $164.0K |
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-4.6M | $-2.8M | ||
| Q2 25 | $-1.5M | $1.1M | ||
| Q1 25 | $-974.0K | — | ||
| Q4 24 | $1.1M | $-1.3M | ||
| Q3 24 | $12.2M | $-4.5M | ||
| Q2 24 | $5.2M | $-1.6M | ||
| Q1 24 | $3.4M | $-15.2M |
| Q4 25 | -2.9% | — | ||
| Q3 25 | -8.7% | -2.3% | ||
| Q2 25 | -3.2% | 0.9% | ||
| Q1 25 | -2.3% | — | ||
| Q4 24 | 1.9% | -1.1% | ||
| Q3 24 | 23.7% | -3.5% | ||
| Q2 24 | 11.0% | -1.4% | ||
| Q1 24 | 7.6% | -12.2% |
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.3% | 5.8% | ||
| Q2 25 | 3.5% | 2.4% | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 1.6% | 5.8% | ||
| Q3 24 | 2.0% | 7.2% | ||
| Q2 24 | 2.3% | 7.1% | ||
| Q1 24 | 1.3% | 12.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
NDLS
| Food And Beverage | $119.6M | 98% |
| Franchise | $2.5M | 2% |
